Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors

Clinical trial NCT04900519 · UNKNOWN

Trial details

NCT number: NCT04900519
Sponsor: Sorrento Therapeutics, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Relapsed Solid Neoplasm Refractory Tumor

Start date: 2021-11-24
Primary completion: 2024-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.